Dr. Shehzad H. Choudry, MD
Pain Medicine (Pain Medicine (Psychiatry & Neurology) Physician)
- Medicare participating
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 318
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pain Medicine (Psychiatry & Neurology) Physician primary
FL license ME141780 -
Interventional Pain Medicine Physician
NC license 2005-01013 -
Neurology Physician
NC license 200501013
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Adventhealth Orlando Orlando, FL
- Orlando Health Orlando, FL
- Orlando Health St Cloud Hospital Saint Cloud, FL
Medical groups
- Orlando Health Medical Group Inc (2,287 clinicians)
- Ability Health Services and Rehabilitation LP (1,269 clinicians)
- Ability Health Services, Inc (1,258 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 318
- Services billed
- 3,547
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, methylprednisolone acetate, 40 mg | 336 | 200 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 299 | 110 |
| New patient office or other outpatient visit, 60-74 minutes | 129 | 129 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 85 | 73 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 82 | 70 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 80 | 64 |
| Injection of substance into lower spine canal using imaging guidance | 55 | 45 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | 36 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 42 | 34 |
| Injection of substance into middle or upper spine canal using imaging guidance | 40 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tramadol Hcl Other prescribers in Orlando, FL | 72 |
| Gabapentin Other prescribers in Orlando, FL | 56 |
| Pregabalin Other prescribers in Orlando, FL | 49 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Orlando, FL | 47 |
| Diazepam Other prescribers in Orlando, FL | 46 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Orlando, FL | 34 |
| Methocarbamol Other prescribers in Orlando, FL | 29 |
| Diclofenac Sodium Other prescribers in Orlando, FL | 26 |
| Tizanidine Hcl Other prescribers in Orlando, FL | 25 |
| Cephalexin Other prescribers in Orlando, FL | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 36 payments worth $8,254 in total to this clinician.
| Medtronic, Inc. | $7,825 |
|---|---|
| Stryker Corporation | $164 |
| Averitas Pharma Inc. | $41.32 |
| Tersera Therapeutics LLC | $38.85 |
| Forte Bio-pharma LLC | $36.39 |
| Curonix LLC | $31.94 |
| Globus Medical, Inc. | $22.27 |
| AbbVie Inc. | $22.15 |
| Compensation for services other than consulting (speaking, faculty) | $6,240 |
|---|---|
| Travel and Lodging | $1,205 |
| Food and Beverage | $777 |
| Education | $31.94 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) INTELLIS ADAPTIVESTIM · Spinal Cord Neurostimulation | $3,900 |
| Medtronic, Inc. Sep 26, 2025 | Compensation for services other than consulting (speaking, faculty) INTELLIS ADAPTIVESTIM · Spinal Cord Neurostimulation | $2,340 |
| Medtronic, Inc. Apr 12, 2025 | Travel and Lodging INTELLIS ADAPTIVESTIM · Spinal Cord Neurostimulation · travel to Miami, FL · in-kind | $338 |
| Medtronic, Inc. Apr 12, 2025 | Travel and Lodging KYPHON EXPRESS II KYPHOPAK TRAY · Neuro Pain (includes Interventional) · travel to Miami, FL · in-kind | $290 |
| Medtronic, Inc. Apr 11, 2025 | Travel and Lodging KYPHON EXPRESS II KYPHOPAK TRAY · Neuro Pain (includes Interventional) · travel to Miami, FL · in-kind | $288 |
| Medtronic, Inc. Apr 12, 2025 | Travel and Lodging KYPHON EXPRESS II KYPHOPAK TRAY · Neuro Pain (includes Interventional) · travel to Miami, FL · in-kind | $256 |
| Medtronic, Inc. Apr 12, 2025 | Travel and Lodging KYPHON EXPRESS II KYPHOPAK TRAY · Neuro Pain (includes Interventional) · travel to Miami, FL · in-kind | $33.28 |
| Curonix LLC Jan 29, 2025 | Education PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PAIN MANAGEMENT · in-kind | $31.94 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $17,120 in research payments for these studies, mostly to the institutions running them.
- Double-Blinded Randomized Control Trial of Knee Pain Utilizing Sub-Threshold Peripheral Nerve Stimulation
Curonix LLC - A Multi-Center, Prospective Clinical Study investigating effectiveness of a novel administration of 10 kHz SCS Therapy
Globus Medical, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.